Whole-exome sequencing (WES) of HER2+ metastatic breast cancer (MBC) from patients (pts) treated with prior trastuzumab (T): A correlative analysis of TBCRC003.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Nikhil Wagle, Nancy U. Lin, Andrea L. Richardson, Ignaty Leshchiner, Ingrid A. Mayer, Andres Forero-Torres, Timothy J. Hobday, Elizabeth Claire Dees, Rita Nanda, Mothaffar F. Rimawi, Hao Guo, William Thomas Barry, Antonio C. Wolff, Stacey B. Gabriel, Levi A. Garraway, Eric P. Winer, Ian E. Krop
Institutions: Dana-Farber Cancer Institute, Brigham and Women's Hospital, Broad Institute, Vanderbilt University, Vanderbilt-Ingram Cancer Center, University of Alabama at Birmingham, Mayo Clinic, UNC Lineberger Comprehensive Cancer Center, University of Chicago, Baylor College of Medicine, Johns Hopkins University, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2772843764